Gaviscon Extra Chewable Tablets

Product Information *

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 06 July 2020

File name

Gaviscon Extra Chew Tabs SmPC_1594036716.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Supply through general sale

Updated on 06 July 2020

File name

Gaviscon Extra Chew Tabs PIL_1594036663.pdf

Reasons for updating

  • Change to section 2 - excipient warnings

Updated on 15 January 2020

File name

Gaviscon Extra Chewable Tablets_1579097211.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 03 January 2018

File name

PIL_14880_825.pdf

Reasons for updating

  • New PIL for new product

Updated on 03 January 2018

Reasons for updating

  • Change to section 1 - what the product is used for

Updated on 02 January 2018

Reasons for updating

  • New SPC for new product

Legal category:Supply through general sale

Updated on 02 January 2018

Reasons for updating

  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Addition to Section 5:
Formation of a protective barrier (raft)
Effective impediment of gastro-oesophageal reflux may last for up to 4 hours. 

Updated on 14 June 2016

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.3 - update to include a reference to section 6.1
Section 4.5 - Addition of thyroid hormones and estramustine as a consideration for interaction with other medicines
Section 4.6 - New data with regards to use during pregnancy
Section 4.8 - Update to format of undesirable effects
Section 10 - update to date of revision of the text

Updated on 20 August 2014

Reasons for updating

  • Introduction of new pack/pack size

Updated on 18 November 2011

Reasons for updating

  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Updated section 9 to include date of last renewal. Resulting in update to section 10

9.      DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

 

         Date of first authorisation:  01st October 2010

         Date of last renewal:  26th January 2011

 

 

10.    DATE OF REVISION OF THE TEXT

         November 2011

 

Updated on 18 January 2011

Reasons for updating

  • New SPC for new product

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

None provided

Updated on 14 January 2011

Reasons for updating

  • New PIL for new product